Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• (untitled)1 passage
• A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape.1 passage
• A 2020 update on liver transplant for hepatocellular carcinoma.1 passage
• A case of rectal carcinoma with skin and bone marrow metastasis with concurrent extensive visceral involvement; unusual and dismal co-incidence.1 passage
• A comprehensive review of the diagnosis and treatment of Parkinson's disease dysphagia and aspiration.1 passage
• A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors.1 passage
• A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients.1 passage
• A critical appraisal of advances in the diagnosis of diverticular disease.1 passage
• A critical appraisal of the use of ultrasound in hepatic steatosis.1 passage
• A current clinical overview of atrophic gastritis.1 passage
• A current overview of corticosteroid use in active ulcerative colitis.1 passage
• A global burden of gastric cancer: the major impact of China.1 passage
• A guide to the management of hepatitis E infection during pregnancy.1 passage
• A mechanism based approach to management of children with end-stage liver disease.1 passage
• A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.1 passage
• A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn's disease patients.1 passage
• A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection.1 passage
• A review of treatment options for bile duct stones.1 passage
• A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD.1 passage
• ABO blood type and risk of hepatocellular carcinoma: a meta-analysis.1 passage
• ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review.1 passage
• Accounting for differences in risk of HCV re-infection by mental health diagnoses.1 passage
• Accreditation of digestive endoscopy services: a method of quality assuring?1 passage
• Achalasia: current treatment options.1 passage
• Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?1 passage
• Achilles'heel of laparoscopic pancreatectomy: reconstruction of the remnant pancreas.1 passage
• Acid suppression in patients treated with endoscopic therapy for the management of gastroesophageal varices: a systematic review and meta-analysis.1 passage
• Acute-on-chronic liver failure 2018: a need for (urgent) liver biopsy?1 passage
• Acute-on-chronic liver failure in chronic hepatitis B: an update.1 passage
• Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.1 passage
• Adenocarcinoma arising from heterotopic gastric mucosa in the cervical esophagus and upper thoracic esophagus: two case reports and literature review.1 passage
• Adoptive cell transfer in autoimmune hepatitis.1 passage
• Advanced endoscopic therapeutics in Barrett's neoplasia: where are we now and where are we heading?1 passage
• Advancement in the clinical management of intestinal pseudo-obstruction.1 passage
• Advancements in the use of manometry and impedance testing for esophageal functional disorders.1 passage
• Advances in clinical nutrition in GI surgery.1 passage
• Advances in endoscopic imaging in ulcerative colitis.1 passage
• Advances in hepatitis E - I: virology, pathogenesis and diagnosis.1 passage
• Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.1 passage
• Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.1 passage
• Advances in radiotherapy delivery for rectal cancer: a European perspective.1 passage
• Advances in the management of childhood portal hypertension.1 passage
• Advances in the removal of diminutive colorectal polyps.1 passage
• Advances in the surgical treatment of hilar cholangiocarcinoma.1 passage
• Advances in the treatment of portal hypertension in cirrhosis.1 passage
• Advances in understanding of colorectal liver metastasis and implications for the clinic.1 passage
• Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease.1 passage
• Advances in understanding the role of cytokines in inflammatory bowel disease.1 passage
• Adverse events in IBD therapy: the 2018 update.1 passage
• Age-associated changes of the intestinal epithelial barrier: local and systemic implications.1 passage
• Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis.1 passage
• Alleviating mucositis: are we on track for a novel therapeutic?1 passage
• Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.1 passage
• An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.1 passage
• An appraisal of current dysphagia diagnosis and treatment strategies.1 passage
• An appraisal of emerging second line therapies for metastatic colorectal cancer.1 passage
• An approach to acute severe ulcerative colitis.1 passage
• An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation.1 passage
• An essential technique for modern hepato-pancreato-biliary surgery: minimally invasive biliary reconstruction.1 passage
• An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults.1 passage
• An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistance.1 passage
• An overview of angiodysplasia: management and patient prospects.1 passage
• An overview of cannabis based treatment in Crohn's disease.1 passage
• An overview of deep learning algorithms and water exchange in colonoscopy in improving adenoma detection.1 passage
• An overview of imaging techniques for liver metastases management.1 passage
• An overview of interventions for constipation in adults.1 passage
• An overview of stereotactic body radiation therapy for hepatocellular carcinoma.1 passage
• An overview of walled-off pancreatic necrosis for clinicians.1 passage
• An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders.1 passage
• An update on biosimilar drugs for inflammatory bowel disease.1 passage
• An update on cirrhotic cardiomyopathy.1 passage
• An update on dietary consideration in inflammatory bowel disease: anthocyanins and more.1 passage
• An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.1 passage
• An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.1 passage
• An update on the pathophysiology and management of polycystic liver disease.1 passage
• An update on the recent advances in antifibrotic therapy.1 passage
• An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets.1 passage
• An update on the strategies used for the treatment of chronic hepatitis B in children.1 passage
• An update on the use of immunotherapy in patients with colorectal cancer.1 passage
• An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study.1 passage
• An updated review on gastro-esophageal reflux in pediatrics.1 passage
• Anemia and iron deficiency in Crohn's disease.1 passage
• Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma.1 passage
• Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach.1 passage
• Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease.1 passage
• Antibiotics for induction and maintenance of remission in ulcerative colitis: systematic review and meta-analysis.1 passage
• Antibiotics in pediatric inflammatory bowel diseases: a systematic review.1 passage
• Apatinib for the treatment of gastric cancer.1 passage
• Appendiceal neoplasm incidence and mortality rates are on the rise in Australia.1 passage
• Apprenticeship-based training in neurogastroenterology and motility.1 passage
• Asbestos ingestion and gastrointestinal cancer: a possible underestimated hazard.1 passage
• Association between non-alcoholic fatty liver disease and colorectal cancer.1 passage
• Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.1 passage
• Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.1 passage
• Autophagy in ethanol-exposed liver disease.1 passage
• BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.1 passage
• Bacillus clausii and gut homeostasis: state of the art and future perspectives.1 passage
• Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.1 passage
• Bariatric embolization: a new and effective option for the obese patient?1 passage
• Best practices in bowel preparation for colorectal surgery: a 2020 overview.1 passage
• Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.1 passage
• Biliary complications after liver transplantation.1 passage
• Biliary tract reconstruction with or without T-tube in orthotopic liver transplantation: a systematic review and meta-analysis.1 passage
• Biological implications and clinical value of mir-210 in gastrointestinal cancer.1 passage
• Biologics and pregnancy: a clinician's guide to the management of IBD in pregnant women.1 passage
• Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?1 passage
• Biomarkers for early diagnosis of pancreatic cancer.1 passage
• Biomarkers for hepatitis B virus replication: an overview and a look to the future.1 passage
• Biomarkers in hepatocellular carcinoma: an overview.1 passage
• Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.1 passage
• Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.1 passage
• Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13.1 passage
• Biosimilars for inflammatory bowel disease: how can healthcare professionals help address patients' concerns?1 passage
• Bone status assessed by quantitative ultrasound in children with inflammatory bowel disease: a comparison with DXA.1 passage
• Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis.1 passage
• Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.1 passage
• COVID-19 in patients with inflammatory bowel disease.1 passage
• CT Colonography: an update on current and future indications.1 passage
• CT assessment of preoperative nutritional status in gastric cancer: severe low skeletal muscle mass and obesity-related low skeletal muscle mass are unfavorable factors of postoperative complications.1 passage
• Can attention to the intestinal microbiota improve understanding and treatment of anorexia nervosa?1 passage
• Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?1 passage
• Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?1 passage
• Capecitabine for the treatment of gastric cancer.1 passage
• Capsule endoscopy - Recent developments and future directions.1 passage
• Capsule endoscopy for patients with coeliac disease.1 passage
• Capsule endoscopy--not just for the small bowel: a review.1 passage
• Celiac disease 2015 update: new therapies.1 passage
• Cell therapy for liver diseases: current medicine and future promises.1 passage
• Cell transplantation as a non-invasive strategy for treating liver fibrosis.1 passage
• Challenges in the multidisciplinary management of stage IV colon and rectal cancer.1 passage
• Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.1 passage
• Challenges of surgical management of intrahepatic cholangiocarcinoma.1 passage
• Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals.1 passage
• Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results.1 passage
• Characteristics of right-sided colonic neoplasia and colonoscopy barriers limiting their early detection and prognosis: a review of the literature.1 passage
• Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence.1 passage
• Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure.1 passage
• Childhood constipation: finally something is moving!1 passage
• Cholangiocarcinoma: new perspectives for new horizons.1 passage
• Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention.1 passage
• Cholesterol is a significant risk factor for non-alcoholic steatohepatitis.1 passage
• Chronic liver disease and oxidative stress - a narrative review.1 passage
• Chronic pancreatitis: an overview of diagnosis and management.1 passage
• Chronic use of statins and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis.1 passage
• Circadian rhythms: a regulator of gastrointestinal health and dysfunction.1 passage
• Circulating microRNAs in nonalcoholic fatty liver disease.1 passage
• Clinical application of hepatocyte transplantation: current status, applicability, limitations, and future outlook.1 passage
• Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review.1 passage
• Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma.1 passage
• Clinical impact of sarcopenia assessment in patients with liver cirrhosis.1 passage
• Clinical implications of understanding the association between oxidative stress and pediatric NAFLD.1 passage
• Clinical management of pediatric achalasia.1 passage
• Clinical management of post-pyloric enteral feeding in children.1 passage
• Clinical presentation and protocol for management of hepatic sarcoidosis.1 passage
• Clinical presentations, management, and outcomes of acute esophageal necrosis: a systemic review.1 passage
• Clinical relevance of liver histopathology and different histological classifications of NASH in adults.1 passage
• Clinical updates on perianal fistulas in Crohn's disease.1 passage
• Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma.1 passage
• Clinical utility of pre-endoscopy risk scores in upper gastrointestinal bleeding.1 passage
• Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening?1 passage
• Combined AFP-CRUT with microvascular invasion accurately predicts mortality risk in patients with hepatocellular carcinoma following curative liver resection.1 passage
• Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study.1 passage
• Combining the serum lactic acid level and the lactate clearance rate into the CLIF-SOFA score for evaluating the short-term prognosis of HBV-related ACLF patients.1 passage
• Comparative efficacy and safety between ablative therapies or surgery for small hepatocellular carcinoma: a network meta-analysis.1 passage
• Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs.1 passage
• Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis.1 passage
• Comparing guideline-based care quality for inflammatory bowel disease and rheumatoid arthritis patients within a medical home.1 passage
• Comparison of efficacy of pharmacological therapies for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and network meta-analysis.1 passage
• Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis.1 passage
• Computed tomography of bowel obstruction: tricks of the trade.1 passage
• Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations.1 passage
• Conditional survival of patients with hepatocellular carcinoma: results from the Surveillance, Epidemiology, and End Results registry.1 passage
• Considerations of heterogeneity in clinical trials for hepatocellular carcinoma.1 passage
• Considering gut microbiota disturbance in the management of Helicobacter pylori infection.1 passage
• Contemporary methods for the diagnosis and treatment of microscopic colitis.1 passage
• Contemporary role of liver transplantation for the treatment of cholangiocarcinoma.1 passage
• Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions.1 passage
• Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration versus standard fine-needle aspiration in pancreatic masses: a meta-analysis.1 passage
• Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failure.1 passage
• Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting.1 passage
• Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients.1 passage
• Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review.1 passage
• Cross-talk between immune system and microbiota in COVID-19.1 passage
• Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis.1 passage
• Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.1 passage
• Current and future treatment options in non-alcoholic steatohepatitis (NASH).1 passage
• Current challenges to underpinning the genetic basis for cholangiocarcinoma.1 passage
• Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma.1 passage
• Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.1 passage
• Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.1 passage
• Current epidemiology in hepatocellular carcinoma.1 passage
• Current evaluation and management of anemia in patients with inflammatory bowel disease.1 passage
• Current evidence on the therapeutic use of fiber in irritable bowel syndrome.1 passage
• Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.1 passage
• Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?1 passage
• Current perspectives on the safety and efficacy of robot-assisted surgery for gastric cancer.1 passage
• Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B.1 passage
• Current role of cyanoacrylate glue transcatheter embolization in the treatment of acute nonvariceal gastrointestinal bleeding.1 passage
• Current standards and new developments of colorectal polyp management and resection techniques.1 passage
• Current status of endoscopic submucosal tunnel dissection for treatment of superficial gastrointestinal neoplastic lesions.1 passage
• Current surgical strategies to treat fecal incontinence.1 passage
• Current treatment options for hepatitis C patients co-infected with HIV.1 passage
• Cutting-edge evidence of adjuvant treatments for gastric cancer.1 passage
• Cyclic vomiting syndrome: an overview for clinicians.1 passage
• DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV.1 passage
• Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.1 passage
• Data sharing during COVID-19 pandemic: what to take away.1 passage
• Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.1 passage
• Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.1 passage
• Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches.1 passage
• Detection and management of early stage inflammatory bowel disease: an update for clinicians.1 passage
• Detection of suspected small bowel bleeding: challenges and controversies.1 passage
• Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C.1 passage
• Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib: a systematic-review and meta-analysis of the impact on survival.1 passage
• Developments in research on interstitial Cajal-like cells in the biliary tract.1 passage
• Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review.1 passage
• Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.1 passage
• Diagnosis and management of renal dysfunction in patients with cirrhosis.1 passage
• Diagnosis and monitoring of postoperative recurrence in Crohn's disease.1 passage
• Diagnosis and treatment of small intestinal bacterial overgrowth.1 passage
• Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.1 passage
• Diagnostic syndromic multiplex approaches for gastrointestinal infections.1 passage
• Dientamoeba fragilis in children: a systematic review on diagnostic considerations and efficacy of treatment.1 passage
• Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease.1 passage
• Dietary therapy for eosinophilic esophagitis: chances and limitations in the clinical practice.1 passage
• Differences between adults and children: genetics and beyond.1 passage
• Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review.1 passage
• Different prognostic significance of signet ring cell histology for early and advanced gastric cancer patients: a systematic review and meta-analysis.1 passage
• Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients.1 passage
• Difficult peroral endoscopic myotomy: definition and management strategies.1 passage
• Dilemma in post-IBD patients with IBS-D symptoms: A 2020 overview.1 passage
• Direct acting antivirals failure: cause and retreatment options.1 passage
• Disease-related and drug-induced skin manifestations in inflammatory bowel disease.1 passage
• Diverticular disease is associated with benign intra-abdominal cystic disease.1 passage
• Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis.1 passage
• Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection.1 passage
• Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.1 passage
• Dual therapy of grazoprevir and elbasvir for the treatment of hepatitis C infection.1 passage
• Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.1 passage
• Effect of the SARS-CoV2 Pandemic on Endoscopy Provision - The Impact of Compliance with National Guidance.1 passage
• Effect of ω-3 polyunsaturated fatty acids on liver function and inflammatory reaction in patients undergoing hepatectomy: a systematic review and meta-analysis of randomized control trials.1 passage
• Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.1 passage
• Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.1 passage
• Effects of Probiotics on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.1 passage
• Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.1 passage
• Efficacy and safety of preoperative biliary drainage in patients undergoing pancreaticoduodenectomy: an updated systematic review and meta-analysis.1 passage
• Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis.1 passage
• Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease.1 passage
• Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis.1 passage
• Elastography methods for the non-invasive assessment of portal hypertension.1 passage
• Electrical therapies for gastrointestinal motility disorders.1 passage
• Elobixibat for the treatment of constipation.1 passage
• Emerging data on nivolumab for esophageal squamous cell carcinoma.1 passage
• Emerging endoscopic techniques for the identification of esophageal disease.1 passage
• Emerging graft protective strategies in clinical liver transplantation.1 passage
• Emerging strategies for the treatment of gastroparesis.1 passage
• Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management.1 passage
• Emerging therapeutic targets and strategies in Crohn's disease.1 passage
• Emerging treatments for primary sclerosing cholangitis.1 passage
• Emerging treatments for short bowel syndrome in adult patients.1 passage
• Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study.1 passage
• Endoscopic imaging in Barrett's esophagus.1 passage
• Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies.1 passage
• Endoscopic incision for treatment of benign gastrointestinal strictures.1 passage
• Endoscopic instruments and techniques in endoscopic submucosal dissection for early gastric cancer.1 passage
• Endoscopic management of choledocholithiasis and cholelithiasis in patients with cirrhosis.1 passage
• Endoscopic management of complications of acute pancreatitis: an update on the field.1 passage
• Endoscopic management of mucosal lesions in the gastrointestinal tract.1 passage
• Endoscopic management of pancreatic pseudocysts and necrosis.1 passage
• Endoscopic management of primary sclerosing cholangitis.1 passage
• Endoscopic resection of submucosal tumors.1 passage
• Endoscopic treatment of benign esophageal strictures: a literature review.1 passage
• Endoscopic versus surgical therapy for Barrett's esophagus neoplasia.1 passage
• Endoscopy after surgery in inflammatory bowel disease: Crohn's disease recurrence and pouch surveillance.1 passage
• Endoscopy for patients affected by inflammatory bowel disease: bowel preparation and sedation.1 passage
• Enteral nutrition in pediatric intestinal failure: does initial feeding impact on intestinal adaptation?1 passage
• Epidemiological investigation of non-fermentative bacterial infection in cirrhotic patients.1 passage
• Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians.1 passage
• Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia.1 passage
• Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East.1 passage
• Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.1 passage
• Epigenetics factors in nonalcoholic fatty liver disease.1 passage
• Esophageal achalasia: current diagnosis and treatment.1 passage
• Esophageal hiatal hernia: risk, diagnosis and management.1 passage
• Evaluating the current surgical strategies for hepatocellular carcinoma.1 passage
• Evaluation of gallbladder wall thickening: a multimodality imaging approach.1 passage
• Evaluation of guidelines for the management of perianal fistulas in Crohn's disease.1 passage
• Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.1 passage
• Evolving techniques for gastrointestinal endoscopic hemostasis treatment.1 passage
• Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors.1 passage
• Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.1 passage
• Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.1 passage
• Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.1 passage
• FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue.1 passage
• Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey.1 passage
• Faecal matrix metalloprotease-9 is a more sensitive marker for diagnosing pouchitis than faecal calprotectin: results from a pilot study.1 passage
• Faldaprevir for the treatment of genotype-1 hepatitis C virus.1 passage
• Familial colorectal cancer syndromes: an overview of clinical management.1 passage
• Fatty liver in pregnancy: a narrative review of two distinct conditions.1 passage
• Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic.1 passage
• Fecal biomarkers in inflammatory bowel disease: how, when and why?1 passage
• Fecal microbiota transplantation for managing irritable bowel syndrome.1 passage
• Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.1 passage
• Fibers in pediatric functional gastrointestinal disorders. Practical considerations from clinical cases.1 passage
• Fibro-indices versus liver stiffness for prediction of significant fibrosis in hepatitis B virus-infected Egyptian patients; a single-center experience.1 passage
• First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges.1 passage
• Fistula-associated anal carcinoma in Crohn's disease.1 passage
• Follow up on atopy and the gastrointestinal tract - a review of a common association 2018.1 passage
• Follow-up on: optimizing lesion detection in small bowel capsule endoscopy and beyond: from present problems to future solutions.1 passage
• Food specific oral immunotherapy: a potential treatment for food allergy.1 passage
• From circadian clocks to non-alcoholic fatty liver disease.1 passage
• From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases.1 passage
• From standard to new genome-based therapy of gastric cancer.1 passage
• Functional abdominal pain disorders and asthma: two disorders, but similar pathophysiology?1 passage
• Functional abdominal pain disorders in children.1 passage
• Functions of circular RNAs and their potential applications in gastric cancer.1 passage
• Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.1 passage
• Gallbladder carcinosarcoma: current perspectives and new development.1 passage
• Gastroduodenal tuberculosis: a case series and a management focused systematic review.1 passage
• Gastroesophageal reflux disease and non-digestive tract diseases.1 passage
• Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management.1 passage
• Gastrointestinal endoscopy in the cirrhotic patient.1 passage
• Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota.1 passage
• Gastrointestinal pathophysiology and nutrition in cystic fibrosis.1 passage
• Genetics and celiac disease: the importance of screening.1 passage
• Genetics and epigenetics purpose in nonalcoholic fatty liver disease.1 passage
• Genetics of pancreatic neuroendocrine tumors: implications for the clinic.1 passage
• Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.1 passage
• Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C.1 passage
• Glucagon like peptide-2 and neoplasia; a systematic review.1 passage
• Golimumab for moderate to severe ulcerative colitis.1 passage
• Grayscale ultrasonography findings for characterization of gallbladder wall thickening in non-acute setting: A systematic review and meta-analysis.1 passage
• Gut microbiota changes and chronic hepatitis C virus infection.1 passage
• Gut microbiota: a target for intervention in obesity.1 passage
• Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis.1 passage
• Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.1 passage
• HMGB1 is a promising therapeutic target for acute liver failure.1 passage
• Hand-foot skin reaction is a beneficial indicator of sorafenib therapy for patients with hepatocellular carcinoma: a systemic review and meta-analysis.1 passage
• Head and neck subcutaneous emphysema, a rare complication of iatrogenic perforation during colonoscopy: management review of reported cases from 2000-2016.1 passage
• Health benefits of Mediterranean diet in nonalcoholic fatty liver disease.1 passage
• Helicobacter pylori drug resistance: therapy changes and challenges.1 passage
• Helicobacter pylori screening: options and challenges.1 passage
• Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease.1 passage
• Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI.1 passage
• Hemoperitoneum in cirrhotic patients in the absence of abdominal trauma.1 passage
• Hepatic gateways.1 passage
• Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patients.1 passage
• Hepatitis B reactivation: diagnosis and management.1 passage
• Hepatitis B-related glomerulonephritis and optimization of treatment.1 passage
• Hepatitis B: treatment choice and monitoring for response and resistance.1 passage
• Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'.1 passage
• Hepatitis C, systemic inflammation and oxidative stress: correlations with metabolic diseases.1 passage
• Hepatitis C: looking into the future.1 passage
• Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa.1 passage
• Hepatitis c virus and chronic kidney disease.1 passage
• Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease.1 passage
• Hepatocyte cell therapy in liver disease.1 passage
• Hepatorenal syndrome: the clinical impact of vasoactive therapy.1 passage
• Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol.1 passage
• High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study.1 passage
• Hospice care for end stage liver disease in the United States.1 passage
• Host homeostatic responses to alcohol-induced cellular stress in animal models of alcoholic liver disease.1 passage
• How do we manage serious gastrointestinal adverse events associated with anti-thrombotic therapy?1 passage
• How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease.1 passage
• Human intestinal parasitic infection: a narrative review on global prevalence and epidemiological insights on preventive, therapeutic and diagnostic strategies for future perspectives.1 passage
• IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis.1 passage
• Identification and management of pancreas divisum.1 passage
• Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices.1 passage
• Identification of new cases of severe enteropathy has recently increased the spectrum of intestinal non-celiac villous atrophy.1 passage
• Imaging in discriminating intestinal tuberculosis and Crohn's disease: past, present and the future.1 passage
• Imaging of perianal fistulizing Crohn's disease.1 passage
• Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials.1 passage
• Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients.1 passage
• Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients.1 passage
• Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.1 passage
• Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials.1 passage
• Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.1 passage
• Implementing psychological therapies for functional GI disorders in children and adults.1 passage
• Implementing psychological therapies for gastrointestinal disorders in pediatrics.1 passage
• Improvements in the management of chronic hepatitis B virus infection.1 passage
• Improving clinical outcomes of chronic hepatitis B virus infection.1 passage
• Improving oncologic outcomes for colorectal cancer at high risk for local-regional recurrence with novel surgical techniques.1 passage
• Improving quality of care in endoscopy of inflammatory bowel disease: can we do better?1 passage
• Improving the management of gastrointestinal bleeding in patients with cirrhosis.1 passage
• In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications?1 passage
• Incidence and mortality of renal dysfunction in cirrhotic patients with acute gastrointestinal bleeding: a systematic review and meta-analysis.1 passage
• Incisional negative pressure wound therapy for clean-contaminated wounds in abdominal surgery: a systematic review and meta-analysis of randomized controlled trials.1 passage
• Indeterminate biliary strictures: a simplified approach.1 passage
• Infections and malignancies risks related to TNF-α-blocking agents in pediatric inflammatory bowel diseases.1 passage
• Inflammatory bowel disease: long-term therapeutic challenges.1 passage
• Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome.1 passage
• Insights and updates on endoscopic papillectomy.1 passage
• Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis.1 passage
• Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.1 passage
• Interactions of helminths with macrophages: therapeutic potential for inflammatory intestinal disease.1 passage
• Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge.1 passage
• Intrahepatic cholangiocarcinoma: current management and emerging therapies.1 passage
• Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.1 passage
• Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis.1 passage
• Iron deficiency anemia in IBD: an overlooked comorbidity.1 passage
• Irritable bowel syndrome and migraine: evidence from Mendelian randomization analysis in the UK Biobank.1 passage
• Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D.1 passage
• Is bioengineering a possibility in gastrointestinal disorders?1 passage
• Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?1 passage
• Is histological healing a feasible endpoint in ulcerative colitis?1 passage
• Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?1 passage
• Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?1 passage
• Is obesity an advantage in patients with colorectal cancer?1 passage
• Is the anesthesiologist necessary in the endoscopy suite? A review of patients, payers and safety.1 passage
• Is there a causal link between psychological disorders and functional gastrointestinal disorders?2 passages
• Is there a role for therapeutic sphingolipids in inflammatory bowel disease?1 passage
• Is there a role for thioguanine therapy in IBD in 2017 and beyond?1 passage
• Is there such a thing as protocol immunosuppression in liver transplantation?1 passage
• Is vitamin D supplementation a viable treatment for Crohn's disease?1 passage
• Ivosidenib for the treatment of isocitrate dehydrogenase-1 mutant cholangiocarcinoma.1 passage
• JAK selectivity: more precision less troubles.1 passage
• Latest advances in diagnosing and predicting DILI: what was new in 2017?1 passage
• Latest advances in the pathological understanding of cholangiocarcinomas.1 passage
• Life on a knife edge: the optimal approach to the management of perforations during endoscopic submucosal dissection (ESD).1 passage
• Limitations of endoscopic ablation in Barrett's esophagus.1 passage
• Limited surgery following neoadjuvant treatment among patients with localized rectal cancer; a population-based study.1 passage
• Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.1 passage
• Liver disease secondary to congenital heart disease in children.1 passage
• Liver fibrosis with two-dimensional shear-wave elastography in patients with autoimmune hepatitis.1 passage
• Liver injury in severe COVID-19 infection: current insights and challenges.1 passage
• Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients.1 passage
• Liver transplant for alcoholic hepatitis: a current clinical overview.1 passage
• Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma.1 passage
• Liver transplantation for perihilar cholangiocarcinoma: patient selection and outcomes.1 passage
• Liver-spleen axis in nonalcoholic fatty liver disease.1 passage
• Long-term effects of appendectomy in humans: is it the optimal management of appendicitis?1 passage
• Luminally expressed gastrointestinal biomarkers.1 passage
• Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD).1 passage
• MAFLD in COVID-19 patients: an insidious enemy.1 passage
• MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.1 passage
• Magnetic endoscopic imaging as a rational investment for specific colonoscopies: a systematic review and meta-analysis.1 passage
• Magnetic resonance enterography of Crohn's disease.1 passage
• Management and diagnosis of fatty liver disease.1 passage
• Management of HCV patients in cases of direct-acting antiviral failure.1 passage
• Management of NSAID-associated peptic ulcer disease.1 passage
• Management of ascites in children.1 passage
• Management of coagulation abnormalities in liver disease.1 passage
• Management of dysphagia in multiple sclerosis: current best practice.1 passage
• Management of early colonic neoplasia: where are we now and where are we heading?1 passage
• Management of gallstones and its related complications.1 passage
• Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years.1 passage
• Management of hepatitis C patients with decompensated liver disease.1 passage
• Management of intrahepatic cholestasis of pregnancy.1 passage
• Management of post-operative Crohn's disease in 2017: where do we go from here?1 passage
• Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.1 passage
• Management of rectovaginal fistulas and patient outcome.1 passage
• Management of serous cystic neoplasms of the pancreas.1 passage
• Management options for cholestatic liver disease in children.1 passage
• Managing cognitive symptoms and fatigue in cholestatic liver disease.1 passage
• Mass Spectrometry as a Clinical Integrative Tool to Evaluate Hepatocellular Carcinoma: Moving to the Mainstream.1 passage
• Maternal and infant factors that shape neonatal gut colonization by bacteria.1 passage
• Medical care of liver transplant patients.1 passage
• Medical professional liability in gastroenterology: definitions, trends, risk factors, provider behaviors, and implications.1 passage
• Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectives.1 passage
• Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.1 passage
• Mesenteric panniculitis: an update.1 passage
• Metabolic disorders and the risk of cholangiocarcinoma.1 passage
• Metabolic endoscopy by duodenal mucosal resurfacing: expert review with critical appraisal of the current technique and results.1 passage
• Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction.1 passage
• Metabolome and microbiome alterations in tongue coating of gastric precancerous lesion patients.1 passage
• Metabolomics studies in gastrointestinal cancer: a systematic review.1 passage
• Metoclopramide for the treatment of diabetic gastroparesis.1 passage
• Microbial modulation of the gut microbiome for treating autoimmune diseases.1 passage
• Microbiota and mucosal defense in IBD: an update.1 passage
• Microbiota transplant therapy and autism: lessons for the clinic.1 passage
• Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma.1 passage
• Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.1 passage
• Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.1 passage
• Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.1 passage
• Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential.1 passage
• Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers.1 passage
• Monitoring of small bowel Crohn's disease.1 passage
• Motilin: a panoply of communications between the gut, brain, and pancreas.1 passage
• Mucosal healing in Crohn's disease: new insights.1 passage
• Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.1 passage
• Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.1 passage
• Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era.1 passage
• Musculoskeletal injuries in gastrointestinal endoscopists: a systematic review.1 passage
• Mycobacterium paratuberculosis as a cause of Crohn's disease.1 passage
• NAFLD and renal function in children: is there a genetic link?1 passage
• Nasogastric aspiration/lavage in patients with gastrointestinal bleeding: a review of the evidence.1 passage
• Natural killer T cells in liver injury, inflammation and cancer.1 passage
• Neo-adjuvant therapy for pancreatic cancer: hope for the future.1 passage
• Neuroendocrine, goblet cell and mixed adeno-neuroendocrine tumours of the appendix: updates, clinical applications and the future.1 passage
• New advances in liver decellularization and recellularization: innovative and critical technologies.1 passage
• New advances in the clinical management of RAS and BRAF mutant colorectal cancer patients.1 passage
• New antibiotic strategies in patients with cirrhosis and bacterial infection.1 passage
• New classifications of gastroesophageal reflux disease: an improvement for patient management?1 passage
• New concept: cellular senescence in pathophysiology of cholangiocarcinoma.1 passage
• New developments in the early diagnosis of pancreatic cancer.1 passage
• New horizons in the imaging of perianal Crohn's disease: transperineal ultrasonography.1 passage
• New insights into the anti-diabetic actions of metformin: from the liver to the gut.1 passage
• New insights into the earliest stages of colorectal tumorigenesis.1 passage
• New insights into the role of vitamin D in hepatocellular carcinoma.1 passage
• New medical strategies for the management of acute diverticulitis.1 passage
• New strategies for the early detection of pancreatic cancer.1 passage
• New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline.1 passage
• New therapies target the toxic consequences of cholestatic liver disease.1 passage
• Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?1 passage
• Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib.1 passage
• Nomograms for predicting survival in early-onset esophageal cancer.1 passage
• Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver.1 passage
• Non-coeliac gluten/wheat sensitivity: advances in knowledge and relevant questions.1 passage
• Non-endoscopic biopsy techniques: a review.1 passage
• Non-healthcare costs of hepatitis C: a systematic review.1 passage
• Non-invasive assessment of liver fibrosis and prognosis.1 passage
• Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers.1 passage
• Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.1 passage
• Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease.1 passage
• Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications.1 passage
• Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV.1 passage
• Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.1 passage
• Noninvasive diagnostic tools for pediatric NAFLD: where are we now?1 passage
• Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease.1 passage
• Normothermic ex-vivo liver perfusion: where do we stand and where to reach?1 passage
• Novel approaches to treating Clostridium difficile-associated colitis.1 passage
• Novel avenues in immunotherapies for colorectal cancer.1 passage
• Novel biliary self-expanding metal stents: indications and applications.1 passage
• Novel biomarkers for the identification and targeted therapy of gastric cancer.1 passage
• Novel diagnostic techniques for celiac disease.1 passage
• Novel directions in neoadjuvant therapy for pancreas adenocarcinoma.1 passage
• Novel imaging strategies for upper gastrointestinal tract cancers.1 passage
• Novel insights into immunotherapy for hepatitis B patients.1 passage
• Novel insights into the development of portal vein thrombosis in cirrhosis patients.1 passage
• Novel insights into the effects of diabetes on gastric motility.1 passage
• Novel pharmacological therapies for irritable bowel syndrome.1 passage
• Novel surgical options for gastroesophageal reflux disease.1 passage
• Novel treatment options for Bouveret's syndrome: a comprehensive review of 61 cases of successful endoscopic treatment.1 passage
• Nutrition in acute pancreatitis: a critical review.1 passage
• Nutrition in peri-operative esophageal cancer management.1 passage
• Obesity and esophageal cancer: GERD, Barrett´s esophagus, and molecular carcinogenic pathways.1 passage
• Obesity and the microbiome.1 passage
• Obesity, diabetes, and the gut microbiome: an updated review.1 passage
• Obeticholic acid for the treatment of nonalcoholic steatohepatitis.1 passage
• Olive oil antioxidants and non-alcoholic fatty liver disease.1 passage
• Ombitasvir and paritaprevir boosted with ritonavir and combined with dasabuvir for chronic hepatitis C.1 passage
• Ongoing challenges and controversies in ulcerative colitis surgery.1 passage
• Ongoing challenges in the diagnosis of hepatocellular carcinoma.1 passage
• Open-label study to evaluate the treatment continuation rate after a dose reduction of lubiprostone due to onset of adverse events.1 passage
• Optimized diagnosis of1 passage
• Optimizing biological therapy in Crohn's disease.1 passage
• Optimizing lesion detection in small-bowel capsule endoscopy: from present problems to future solutions.1 passage
• Optimizing the diagnosis and the treatment of iron overload diseases.1 passage
• Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection.1 passage
• Optogenetic control of the enteric nervous system and gastrointestinal transit.1 passage
• Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatments.1 passage
• Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort study.1 passage
• Overview of small bowel angioectasias: clinical presentation and treatment options.1 passage
• Oxaliplatin in perioperative chemotherapy for gastric and gastroesophageal junction (GEJ) adenocarcinoma.1 passage
• PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD.1 passage
• Pancreas volume in health and disease: a systematic review and meta-analysis.1 passage
• Pancreatic reconstruction techniques after pancreaticoduodenectomy: a review of the literature.1 passage
• Parasitic and infectious diseases of the biliary tract in migrants and international travelers.1 passage
• Particularities of Crohn's disease in pediatric patients: current status and perspectives regarding imaging modalities.1 passage
• Pathophysiology of diverticular disease.1 passage
• Patient's profiling for therapeutic management of inflammatory bowel disease: a tailored approach.1 passage
• Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues.1 passage
• Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration.1 passage
• Patients' perception of colonoscopy and acceptance of colonoscopy based IBD related colorectal cancer surveillance.1 passage
• Pediatric NAFLD: an overview and recent developments in diagnostics and treatment.1 passage
• Pediatric irritable bowel syndrome and other functional abdominal pain disorders: an update of non-pharmacological treatments.1 passage
• Pediatric liver diseases: current challenges and future perspectives.1 passage
• Pediatric liver transplantation: a North American perspective.1 passage
• Peretinoin as an adjuvant therapy for hepatocellular carcinoma.1 passage
• Periodontal and dental health in inflammatory bowel diseases: a systematic review.1 passage
• Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma.1 passage
• Perioperative management of ileocecal Crohn's disease in the current era.1 passage
• Perspectives on the interlinked nature of systemic sclerosis and reflux disease.1 passage
• Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.1 passage
• Pharmacologic management of primary sclerosing cholangitis: what's in the pipeline?1 passage
• Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease.1 passage
• Physiology and pathophysiology of liver lipid metabolism.1 passage
• Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer.1 passage
• Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.1 passage
• Pneumococcal vaccination in celiac disease.1 passage
• Portal hypertensive gastropathy with a focus on management.1 passage
• Post-cholecystectomy syndrome and sphincter of Oddi dysfunction: past, present and future.1 passage
• Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea.1 passage
• Postprandial distress syndrome: stratification and management.1 passage
• Practical gastrointestinal investigation of iron deficiency anaemia.1 passage
• Pre-operative staging of rectal cancer: a review of imaging techniques.1 passage
• Precision medicine for metastatic colorectal cancer: an evolving era.1 passage
• Predicting outcomes in acute severe ulcerative colitis.1 passage
• Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system.1 passage
• Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges.1 passage
• Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art.1 passage
• Primary liver cancer genome sequencing: translational implications and challenges.1 passage
• Primary prevention of Clostridium difficile infections - how difficult can it be?1 passage
• Primary sclerosing cholangitis in children versus adults: lessons for the clinic.1 passage
• Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.1 passage
• Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art.1 passage
• Prognostic factors in patients treated with transarterial radioembolization for unresectable and chemorefractory colorectal cancer with liver metastases.1 passage
• Prognostic markers in esophageal cancer: from basic research to clinical use.1 passage
• Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.1 passage
• Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients.1 passage
• Progress in promising anti-fibrotic therapies.1 passage
• Progress in the serology-based diagnosis and management of adult celiac disease.1 passage
• Proposal of a novel stage grouping of the Eighth Edition of American Joint Committee on Cancer TNM Staging System for Gastric Cancer: results from a retrospective study of 30 years clinical data from a single institute in China.1 passage
• Proposed therapies in primary biliary cholangitis.1 passage
• Protein kinase D enzymes: novel kinase targets in pancreatic cancer.1 passage
• Prucalopride for the treatment of constipation: a view from 2015 and beyond.1 passage
• Prucalopride succinate for the treatment of constipation: an update.1 passage
• Quality assessment of clinical practice guidelines for eosinophilic esophagitis using the AGREE II instrument.1 passage
• Quality of colonoscopy and advances in detection of colorectal lesions: a current overview.1 passage
• Quality of life after surgery for rectal cancer: a systematic review of comparisons with the general population.1 passage
• Quantification of hepatic functional capacity: a call for standardization.1 passage
• Radiation-induced liver disease in the era of SBRT: a review.1 passage
• Radiofrequency ablation for management of malignant biliary obstruction: a single-center experience and review of the literature.1 passage
• Ramucirumab for gastric cancer.1 passage
• Randomized, placebo-controlled trial of xyloglucan and gelose for the treatment of acute diarrhea in children.1 passage
• Ranson score to stratify severity in Acute Pancreatitis remains valid - Old is gold.1 passage
• Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.1 passage
• Recent advances in diagnostic testing for gastroesophageal reflux disease.1 passage
• Recent advances in pediatric celiac disease.1 passage
• Recent advances in pediatric gastrointestinal endoscopy: an overview.1 passage
• Recent advances in the diagnosis of irritable bowel syndrome.1 passage
• Recent advances in the management of perianal fistulizing Crohn's disease: lessons for the clinic.1 passage
• Recent advances in the pathological understanding of eosinophilic esophagitis.1 passage
• Recent advances in the treatment of primary sclerosing cholangitis.1 passage
• Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.1 passage
• Recent advances of immunotherapy for biliary tract cancer.1 passage
• Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy.1 passage
• Recent insights on the use of topical steroids in eosinophilic esophagitis.1 passage
• Recurrence of hepatocellular carcinoma following liver transplantation.1 passage
• Red cell distribution width to platelet ratio for liver fibrosis: a systematic review and meta-analysis of diagnostic accuracy.1 passage
• Refractory celiac disease.1 passage
• Renal complications of liver diseases.1 passage
• Restoring gut physiology in short bowel patients: from bench to clinical application of autologous intestinal reconstructive procedures.1 passage
• Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.1 passage
• Reviewing the diagnostic criteria for acute-on-chronic liver failure.1 passage
• Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.1 passage
• Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.1 passage
• Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis.1 passage
• Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort.1 passage
• Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy.1 passage
• Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.1 passage
• Role of histone deacetylase on nonalcoholic fatty liver disease.1 passage
• Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review.1 passage
• Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis.1 passage
• Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma: from diagnosis and prognosis to treatment response.1 passage
• Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.1 passage
• Role of the biliary microbiome in gallstone disease.1 passage
• Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications.1 passage
• Safety and efficacy of indocyanine green fluorescence imaging-guided radical gastrectomy: a systematic review and meta-analysis.1 passage
• Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.1 passage
• Sarcopenia and chronic liver diseases.1 passage
• Sarcopenia in chronic liver diseases: a translational overview.1 passage
• Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice.1 passage
• Scoring model to predict outcome in critically ill cirrhotic patients with acute respiratory failure: comparison with MELD scoring models and CLIF-SOFA score.1 passage
• Seasonal clustering in inflammatory bowel disease: a single centre experience.1 passage
• Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers.1 passage
• Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post- endoscopic retrograde cholangiopancreatography pancreatitis.1 passage
• Selective use of liver transplantation for severe alcohol-associated hepatitis.1 passage
• Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study.1 passage
• Short bowel syndrome in children and adults: from rehabilitation to transplantation.1 passage
• Should biologic agents be stopped before surgery for inflammatory bowel disease?1 passage
• Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa.1 passage
• Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study.1 passage
• Skills over pills? A clinical gastroenterologist's primer in cognitive behavioral therapy for irritable bowel syndrome.1 passage
• Small bowel villous atrophy: celiac disease and beyond.1 passage
• Sofosbuvir and velpatasvir for the treatment of hepatitis C.1 passage
• Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.1 passage
• Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence.1 passage
• Sofosbuvir, velpatasvir and voxilaprevir combination for the treatment of hepatitis C.1 passage
• Sofosbuvir/velpatasvir for the treatment of hepatitis C in pediatric patients.1 passage
• Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study.1 passage
• Spleen angiosarcoma: a world review.1 passage
• Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).1 passage
• Spontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatments.1 passage
• Sterile inflammation in acute liver injury: myth or mystery?1 passage
• Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure.1 passage
• Supersonic shear imaging for the diagnosis of liver fibrosis and portal hypertension in liver diseases: a meta-analysis.1 passage
• Surgical choice of proximal gastric cancer in China: a retrospective study of a 30-year experience from a single center in China.1 passage
• Surveillance strategies for colitis-associated cancer: state of the art and future perspectives.1 passage
• Survival analysis of colorectal cancer patients in a Thai hospital-based cancer registry.1 passage
• Survival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments.1 passage
• Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies.1 passage
• Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis.1 passage
• Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.1 passage
• Symptom management in inflammatory bowel disease.1 passage
• Synergistic impact of resection margin and microscopic vascular invasion for patients with HBV-related intrahepatic cholangiocarcinoma.1 passage
• Systematic review and meta-analysis of the association between IL18RAP rs917997 and CCR3 rs6441961 polymorphisms with celiac disease risks.1 passage
• Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs).1 passage
• Systematic review and meta-analysis: is bowel preparation still necessary in small bowel capsule endoscopy?1 passage
• Systematic review: the etiology of esophageal squamous cell carcinoma in low-income settings.1 passage
• T-tube or no T-tube for biliary tract reconstruction in orthotopic liver transplantation: an updated systematic review and meta-analysis.1 passage
• Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.1 passage
• Targeted therapy in esophageal cancer.1 passage
• Targeting endoplasmic reticulum stress in liver disease.1 passage
• Targeting the gut layers in Crohn's disease: mucosal or transmural healing?1 passage
• Technical interventions to increase adenoma detection rate in colonoscopy.1 passage
• Teduglutide for pediatric short bowel syndrome patients.1 passage
• Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?1 passage
• Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics.1 passage
• Terminal ileal intubation and biopsy in routine colonoscopy practice.1 passage
• The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.1 passage
• The UK-DCD-Risk-Score - practical and new guidance for allocation of a specific organ to a recipient?1 passage
• The association between deprivation and the incidence and survival of patients with hepatocellular carcinoma in the West of Scotland.1 passage
• The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies.1 passage
• The benefits of exercise for patients with non-alcoholic fatty liver disease.1 passage
• The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery.1 passage
• The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis.1 passage
• The challenges of liver transplantation in children with primary sclerosing cholangitis.1 passage
• The cheating liver: imaging of focal steatosis and fatty sparing.1 passage
• The clinical application of camrelizumab on advanced hepatocellular carcinoma.1 passage
• The clinical impact of cirrhosis on the postoperative outcomes of patients undergoing bariatric surgery: propensity score-matched analysis of 2011-2017 US hospitals.1 passage
• The current knowledge about the therapeutic use of endoscopic sclerotherapy and endoscopic tissue adhesives in variceal bleeding.1 passage
• The current situation and challenges of screening for and treating hepatitis B in sub-Saharan Africa.1 passage
• The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation.1 passage
• The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome.1 passage
• The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism.1 passage
• The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study.1 passage
• The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study.1 passage
• The endoscopist's role in the diagnosis and management of pancreatic cancer.1 passage
• The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal.1 passage
• The evolving epidemiology of hepatocellular carcinoma: a global perspective.1 passage
• The future of the Roux-en-Y gastric bypass.1 passage
• The gallbladder polypoid-lesions conundrum: moving forward with controversy by looking back.1 passage
• The high-dose amoxicillin-proton pump inhibitor dual therapy in eradication of1 passage
• The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?1 passage
• The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease.1 passage
• The influence of the gastrointestinal microbiome on infant colic.1 passage
• The interrelation between lipid profile in chronic HCV patients and their response to antiviral agents.1 passage
• The intestinal barrier: a fundamental role in health and disease.1 passage
• The intestinal tissue homeostasis - the role of extracellular matrix remodeling in inflammatory bowel disease.1 passage
• The management of 'hard-to-prepare' colonoscopy patients.1 passage
• The management of autoimmunity in patients with cholestatic liver diseases.1 passage
• The mechanism of esophagus dysmotility in diabetes and research progress of relating treatments.1 passage
• The multidisciplinary approach to the treatment of rectal cancer: 2015 update.1 passage
• The oral refeeding trilemma of acute pancreatitis: what, when and who?1 passage
• The pediatric Rome IV criteria: what's new?1 passage
• The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.1 passage
• The potential of gut microbiota and fecal volatile organic compounds analysis as early diagnostic biomarker for necrotizing enterocolitis and sepsis in preterm infants.1 passage
• The potential role of statins in treating liver disease.1 passage
• The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir + asunaprevir.1 passage
• The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.1 passage
• The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer.1 passage
• The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis.1 passage
• The risk factors for delayed bleeding after endoscopic resection of colorectal tumors: a meta-analysis.1 passage
• The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.1 passage
• The role and advances of immunomodulator therapy for inflammatory bowel disease.1 passage
• The role of a plant-based diet in the pathogenesis, etiology and management of the inflammatory bowel diseases.1 passage
• The role of adult living donor liver transplantation and recent advances.1 passage
• The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.1 passage
• The role of capsule endoscopy in assessing mucosal inflammation in ulcerative colitis.1 passage
• The role of cell-free DNA in predicting colorectal cancer prognosis.1 passage
• The role of chronic inflammation in the development of gastrointestinal cancers: reviewing cancer prevention with natural anti-inflammatory intervention.1 passage
• The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs.1 passage
• The role of dietary patterns in colorectal cancer: a 2019 update.1 passage
• The role of endoscopic doppler probe in the management of bleeding peptic ulcers: a systematic review and meta-analysis.1 passage
• The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy.1 passage
• The role of gene-environment interactions in the development of food allergy.1 passage
• The role of hypoxia in pancreatic cancer: a potential therapeutic target?1 passage
• The role of imaging and biopsy in the management and staging of large non-pedunculated rectal polyps.1 passage
• The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.1 passage
• The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?1 passage
• The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.1 passage
• The role of mucoprotectants in the management of gastrointestinal disorders.1 passage
• The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review.1 passage
• The role of stem cells in liver injury and repair.1 passage
• The role of the chronic care model in promoting the management of the patient with rare liver disease.1 passage
• The role of vitamin D in inflammatory bowel disease: a guide for clinical practice.1 passage
• The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13.1 passage
• The surgical management of gallbladder cancer.1 passage
• The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis.1 passage
• The use of alvimopan for postoperative ileus in small and large bowel resections.1 passage
• The use of human albumin in patients with cirrhosis: a European survey.1 passage
• The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives.1 passage
• The use of peripheral blood mononuclear cells in celiac disease diagnosis and treatment.1 passage
• The validity of suspected blood indicator software in capsule endoscopy: a systematic review and meta-analysis.1 passage
• The vascular endothelial growth factor signaling pathway regulates liver sinusoidal endothelial cells during liver regeneration after partial hepatectomy.1 passage
• Therapeutic challenges of managing inflammatory bowel disease in the elderly patient.1 passage
• Therapeutic implication of platelets in liver regeneration -hopes and hues.1 passage
• Thiopurine-induced pancreatitis in inflammatory bowel diseases.1 passage
• Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study.1 passage
• To cap/cuff or ring: do distal attachment devices improve the adenoma detection?1 passage
• Toxicity and response to thiopurines in patients with inflammatory bowel disease.1 passage
• Training in endoscopic retrograde cholangio-pancreatography: a critical assessment of the broad scenario of training programs and models.1 passage
• Transhiatal versus transthoracic surgical approach for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis.1 passage
• Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further?1 passage
• Treating acute pancreatitis: what's new?1 passage
• Treatment of Clostridium difficile infection in pediatric patients.1 passage
• Treatment of childhood constipation: a synthesis of systematic reviews and meta-analyses.1 passage
• Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?1 passage
• Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.1 passage
• Trifluridine/tipiracil for the treatment of metastatic gastric cancer.1 passage
• Two-dimensional shear wave elastography for screening varices in Asian patients with primary biliary cholangitis.1 passage
• Ultrathin choledochoscope improves outcomes in the treatment of gallstones and suspected choledocholithiasis.1 passage
• Uncut Roux-en-Y reconstruction after distal gastrectomy for gastric cancer.1 passage
• Understanding gastroschisis and its clinical management: where are we?1 passage
• Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.1 passage
• Understanding the association between diet and nutrition in upper gastrointestinal cancer.1 passage
• Understanding the relationship between esophageal motor disorders and reflux disease.1 passage
• Understanding the sensory irregularities of esophageal disease.1 passage
• Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer.1 passage
• Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?1 passage
• Unmet needs in treating laryngo-pharyngeal reflux disease: where do we go from here?1 passage
• Unrecognized anemia after whipple - should we learn from gastric bypass?1 passage
• Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn's disease?1 passage
• Update on dietary therapy for eosinophilic esophagitis in children and adults.1 passage
• Updated evidence on adjuvant treatments for gastric cancer.1 passage
• Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy.1 passage
• Updates in association of gastroesophageal reflux disease and dental erosion: systematic review.1 passage
• Updates in the field of autoimmune pancreatitis: a clinical guide.1 passage
• Updates in the field of hereditary nonpolyposis colorectal cancer.1 passage
• Updates in the field of non-esophageal gastroesophageal reflux disorder.1 passage
• Updates in the management of hepatitis B in children.1 passage
• Updates on vaccinating the inflammatory bowel disease patient.1 passage
• Upper gastrointestinal hemorrhage in acute-on-chronic liver failure: prevalence, characteristics, and impact on prognosis.1 passage
• Urban-rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis.1 passage
• Use of antibiotic prophylaxis is not needed for endoscopic ultrasound-guided fine-needle aspiration of pancreatic cysts: a meta-analysis.1 passage
• Using stents in the management of malignant bowel obstruction: the current situation and future progress.1 passage
• Ustekinumab for the treatment of Crohn's disease.1 passage
• Utility of point shear wave elastography in characterisation of focal liver lesions.1 passage
• Utilizing artificial intelligence in endoscopy: a clinician's guide.1 passage
• Vaccinating the inflammatory bowel disease patient.1 passage
• Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.1 passage
• Vedolizumab for the treatment of ulcerative colitis.1 passage
• Vedolizumab in the treatment of Crohn's disease.1 passage
• Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir.1 passage
• Visceral fat is associated with cirrhotic portal vein thrombosis.1 passage
• Vitamin A and inflammatory bowel diseases: from cellular studies and animal models to human disease.1 passage
• What's new in the treatment of portopulmonary hypertension?1 passage
• Wheat-related disorders reviewed: making a grain of sense.1 passage
• Which patients benefit from preoperative biliary drainage in resectable pancreatic cancer?1 passage
• Which patients with inflammatory bowel disease should receive combination therapy?1 passage
• Who and how to screen for cancer in at-risk inflammatory bowel disease patients.1 passage
• Why is colorectal cancer increasing in younger age groups in the United States?1 passage